CBD Calming Cat Treat Market Size, Share & Growth Analysis, 2026-2034

This report is updated with the latest market data and insights as of June 2026. Base year: 2025  |  Forecast period: 2026-2034

CBD Calming Cat Treat Market Size and Growth Outlook

Our analysis shows that the global CBD Calming Cat Treats market size reached USD 372 million in 2025, reflecting robust expansion driven by increasing pet wellness trends and the legalization of CBD-based products in several key markets. The industry is projected to grow at a CAGR of 16.4% from 2026 to 2034, with the market expected to reach USD 1.41 billion by 2034. This impressive growth is largely attributed to heightened consumer awareness about the benefits of CBD for pets, particularly in managing anxiety and stress, and the proliferation of innovative product offerings tailored to feline health.

Get Free Sample Report

One of the primary growth drivers for the CBD Calming Cat Treats market is the increasing prevalence of pet ownership worldwide, especially among millennials and Gen Z consumers who treat pets as family members. This demographic shift has amplified demand for premium pet care products, including those formulated with natural and functional ingredients like CBD. The growing body of scientific evidence supporting the efficacy of CBD in alleviating feline anxiety, stress, and chronic pain has further fueled consumer confidence, resulting in greater adoption rates. Additionally, the rise of holistic pet care philosophies has led pet owners to seek alternatives to traditional pharmaceuticals, propelling the popularity of CBD pet treats as a mainstream wellness option.

Another significant factor contributing to market expansion is the evolving regulatory landscape that increasingly favors the use of hemp-derived CBD in pet products. Countries such as the United States, Canada, and several European nations have taken progressive steps to clarify and legalize the use of CBD in animal wellness, thereby encouraging manufacturers to innovate and expand their product portfolios. The growing acceptance of CBD as a safe and effective supplement for pets has also encouraged veterinary professionals to recommend these products more frequently, further legitimizing their use and driving market growth. Additionally, advancements in extraction technologies and formulation science have enabled companies to develop more palatable, bioavailable, and targeted treats, catering to specific feline health needs.

The rapid expansion of e-commerce and digital marketing has also played a pivotal role in boosting the CBD Calming Cat Treats market. Online retail platforms have democratized access to a wide variety of CBD-infused pet products, enabling consumers to research, compare, and purchase treats from the comfort of their homes. Digital channels have also facilitated direct-to-consumer engagement, allowing brands to educate pet owners about the benefits and safety of CBD, thereby accelerating market penetration. Social media influencers and pet wellness blogs have further amplified awareness and trust, fostering a community-driven approach to product discovery and adoption. As a result, online sales channels have emerged as a critical growth lever for both established and emerging market players.

From a regional perspective, North America remains the dominant market for CBD Calming Cat Treats, accounting for over 48% of global revenue in 2025. This leadership position is underpinned by a favorable regulatory environment, high pet ownership rates, and a mature CBD industry. Europe follows closely, with increasing legalization and consumer acceptance driving significant growth, particularly in countries such as the UK, Germany, and France. The Asia Pacific region, while currently representing a smaller share, is poised for rapid growth due to rising disposable incomes, urbanization, and evolving pet care attitudes. Latin America and the Middle East and Africa are also witnessing gradual uptake as regulatory frameworks and consumer awareness continue to develop.

As the market for CBD Calming Cat Treats continues to expand, there is a notable trend toward the incorporation of broader pet wellness routines that span multiple product formats. The versatility of these solutions allows for tailored approaches to feline health, addressing not only anxiety and stress but also conditions such as joint pain and skin irritation. This holistic approach is resonating with consumers who increasingly prioritize natural and preventative health measures for their pets. As more research supports the benefits of CBD for cats, the integration of these products into daily pet care regimens is expected to become more commonplace, further driving market growth through 2034.

CBD Calming Cat Treat Market by Product Type

The Product Type segment of the CBD Calming Cat Treats market is characterized by a diverse array of offerings, including soft chews, crunchy treats, biscuits, and other innovative formulations. Among these, soft chews have emerged as the most popular product type, capturing approximately 46.5% of market share in 2025 due to their palatability and ease of administration. The soft, pliable texture of these treats is particularly appealing to cats, who can be notoriously finicky eaters, and allows for precise dosing of CBD. Manufacturers have leveraged advancements in flavor technology to mask the natural taste of hemp, further enhancing acceptance among feline consumers. As a result, soft chews are frequently recommended by veterinarians for their efficacy in delivering consistent CBD dosages and their suitability for cats with dental sensitivities.

Get Free Sample Report

Crunchy treats appeal to cat owners seeking a more traditional snack format that promotes dental health alongside calming benefits. These products are often formulated with additional functional ingredients such as omega fatty acids or probiotics to support overall feline wellness, and hold roughly 26.0% of market share in 2025. The crunchy texture helps reduce tartar buildup, making them a preferred choice for pet owners concerned about oral hygiene. Their popularity is rising as manufacturers introduce new flavors and formulations tailored to specific health needs, including grain-free and hypoallergenic options catering to cats with dietary sensitivities. The broader cat treats category is also benefiting from this functional ingredient trend, reinforcing product innovation across formats.

Biscuits represent another important sub-segment within the product type category, holding around 16.5% of market share in 2025, offering a convenient and portable option for on-the-go pet owners. These treats are typically baked to achieve a firm texture and are often infused with complementary botanicals such as chamomile or valerian root to enhance their calming effects. The biscuit format is favored for its longer shelf life and ease of storage, making it a practical choice for multi-pet households or those who travel frequently with their cats. Ongoing product innovation and the introduction of mini-sized variants are expected to drive further growth in this sub-segment through 2034.

Other product types, including CBD-infused pastes, gels, and liquid drops, account for approximately 11.0% of the market in 2025 and are gaining traction among consumers seeking alternative delivery methods for cats with specific health or behavioral concerns. These formulations offer greater flexibility in dosing and can be easily mixed with food or administered directly, making them suitable for cats with dietary restrictions or aversions to traditional treats. The growing demand for customized and targeted solutions is encouraging manufacturers to expand their product portfolios and invest in research and development, further diversifying the market landscape. Consumers exploring CBD-free alternatives for pet calming are also influencing product innovation, pushing brands to develop hybrid and multi-ingredient formulations that cater to a broader range of consumer preferences.

CBD Calming Cat Treat Market Report Scope

CBD Calming Cat Treat Market by Application

The Application segment of the CBD Calming Cat Treats market is primarily driven by the growing recognition of CBD's therapeutic potential in addressing various feline health concerns. Anxiety and stress relief remains the leading application, accounting for over 52% of market revenue in 2025. Cats are highly susceptible to environmental stressors such as changes in routine, loud noises, or new household members, which can manifest as behavioral issues or physical symptoms. CBD calming treats offer a natural, non-pharmacological solution to mitigate these effects, providing pet owners with a safe and effective tool to enhance feline well-being. The increasing prevalence of anxiety-related disorders in cats, coupled with the desire for holistic pet care, has fueled demand for products specifically formulated to promote relaxation and emotional balance.

In addition to CBD-based options, calming treats for pets formulated with chamomile, valerian root, and other botanicals are emerging as a significant complementary category within the pet wellness industry. The demand for such products is being driven by pet owners increasingly aware of the impact of stress on their pets' overall health and behavior. These treats offer a convenient and effective way to provide pets with the benefits of calming ingredients, making them an attractive option for managing everyday stressors such as travel, thunderstorms, or separation anxiety. As the market for pet wellness products expands, multi-ingredient calming solutions are expected to play a pivotal role in enhancing quality of life for both pets and their owners through 2034.

Pain management represents another significant application area, particularly for aging cats or those suffering from chronic conditions such as arthritis or inflammatory diseases. CBD's anti-inflammatory and analgesic properties have been widely documented in scientific literature, and anecdotal evidence from pet owners further supports its efficacy in reducing pain and improving mobility. The availability of targeted formulations, including those enriched with joint-supporting ingredients like glucosamine and chondroitin, has broadened the appeal of CBD treats among pet owners seeking to enhance their cats' quality of life. As the feline population continues to age, the demand for pain management solutions is expected to rise, driving further growth in this application segment through 2034.

General wellness is an increasingly important application for CBD calming cat treats, as pet owners adopt a proactive approach to feline health. Products positioned for overall wellness often contain a blend of CBD and other functional ingredients such as antioxidants, vitamins, and minerals to support immune function, digestion, and skin health. The holistic benefits of CBD, including its potential to reduce inflammation, support cardiovascular health, and improve appetite, have resonated with health-conscious consumers. This trend is particularly pronounced among younger pet owners who are more likely to invest in preventive health measures and seek out products with clean, natural ingredients.

Other applications, such as seizure management, digestive support, and post-surgical recovery, are gaining attention as research into CBD's therapeutic effects continues to expand. While these use cases currently represent a smaller share of the market, ongoing clinical studies and anecdotal reports are expected to drive increased adoption through the forecast period. The growing willingness of veterinarians to recommend CBD-based products for a wider range of health concerns is also contributing to the diversification of application areas. As scientific understanding deepens and regulatory frameworks evolve, the application segment is poised for continued innovation and expansion.

CBD Calming Cat Treat Market by Distribution Channel

The Distribution Channel segment of the CBD Calming Cat Treats market is undergoing rapid transformation, driven by shifting consumer preferences and the rise of digital commerce. Online stores have emerged as the dominant channel, accounting for approximately 40% of global sales in 2025. The convenience, variety, and competitive pricing offered by e-commerce platforms have made them the preferred choice for pet owners seeking CBD-infused treats. Online retailers also provide detailed product information, customer reviews, and educational resources, empowering consumers to make informed purchasing decisions. Subscription-based models have further strengthened the online channel, ensuring repeat purchases and deeper brand loyalty for leading players.

Pet specialty stores remain a key distribution channel, particularly for consumers who value personalized service and expert advice. These brick-and-mortar retailers often employ knowledgeable staff who can guide pet owners in selecting the most appropriate products for their cats' specific needs. The ability to physically inspect products and consult with in-store experts has helped specialty stores maintain a loyal customer base, despite the growth of online channels. Many pet specialty retailers have also expanded their offerings to include a wider range of CBD-infused treats, capitalizing on the growing demand for natural and functional pet care products. Pet owners interested in comparing options with non-CBD calming chew formats can often find these alternatives stocked alongside CBD lines in specialty retail environments.

Veterinary clinics represent a trusted distribution channel for CBD calming cat treats, particularly among pet owners seeking professional guidance and assurance of product safety. The endorsement of veterinarians lends credibility to CBD-infused products and can significantly influence purchasing decisions. As regulatory clarity improves and clinical evidence supporting the efficacy of CBD continues to mount, more veterinary practices are incorporating these products into their retail offerings. This trend is expected to gain momentum through 2034, particularly in markets where veterinary oversight is required for the sale of CBD-based pet supplements.

Supermarkets and hypermarkets are increasingly stocking CBD calming cat treats, reflecting the mainstreaming of CBD products and growing consumer demand. These mass-market retailers offer the advantage of convenience and accessibility, enabling pet owners to purchase treats alongside their regular grocery shopping. The entry of major retail chains into the CBD pet products space has contributed to greater visibility and normalization of these products, driving incremental sales. Other distribution channels, such as independent pet stores, holistic health shops, and direct-to-consumer models, continue to play a role in reaching niche markets and fostering brand loyalty.

CBD Calming Cat Treat Market by CBD Source

The CBD Source segment is a critical factor in the CBD Calming Cat Treats market, as it directly influences product legality, safety, and consumer perception. Hemp-derived CBD currently dominates the market, accounting for over 85% of total sales in 2025. This dominance is largely due to the widespread legalization of hemp-derived CBD, which contains less than 0.3% THC and is considered non-psychoactive. The safety profile and regulatory acceptance of hemp-derived CBD have made it the preferred choice for pet products, with manufacturers emphasizing third-party testing and transparent sourcing to build consumer trust. The proliferation of certified organic and non-GMO hemp sources has further enhanced the appeal of these products among health-conscious pet owners.

Marijuana-derived CBD, while offering similar therapeutic benefits, is subject to stricter regulatory controls due to its higher THC content. As a result, its use in pet products is limited to jurisdictions with comprehensive cannabis legalization frameworks. In markets where marijuana-derived CBD is permitted, manufacturers must adhere to stringent quality and safety standards, including rigorous testing for THC levels and contaminants. Despite these challenges, there is a niche but growing demand for marijuana-derived CBD treats among pet owners seeking full-spectrum formulations that leverage the entourage effect. However, concerns about potential psychoactive effects and legal restrictions have limited widespread adoption of marijuana-derived CBD in the feline market as of 2025.

The choice of CBD source also impacts product positioning and marketing strategies. Hemp-derived products are often marketed as safe, legal, and suitable for daily use, appealing to mainstream consumers and those new to CBD. In contrast, marijuana-derived products may be positioned as premium or specialized offerings, targeting experienced users or those seeking advanced therapeutic benefits. The ability to differentiate products based on CBD source, cannabinoid profile, and extraction method is becoming increasingly important as the market matures and competition intensifies.

As regulatory frameworks continue to evolve and consumer awareness grows, the CBD source segment is expected to witness ongoing innovation and diversification through 2034. Manufacturers are investing in advanced extraction technologies such as CO2 and ethanol extraction to ensure product purity and consistency. The development of broad-spectrum and isolate formulations, which contain varying levels of cannabinoids and terpenes, is enabling brands to tailor products to specific consumer preferences and health needs. Transparent labeling and third-party certification will remain critical differentiators in building trust and driving sustained market growth. Meanwhile, the growth of herbal cat calming spray formats signals consumer openness to a diverse range of ingredient-led solutions beyond CBD alone.

CBD Calming Cat Treat Market Opportunities and Threats

The CBD Calming Cat Treats market presents a host of compelling opportunities for industry participants, particularly in the areas of product innovation, market expansion, and consumer education. The growing acceptance of CBD as a safe and effective supplement for pet wellness has created fertile ground for the development of novel formulations and delivery systems. Companies that invest in research and development to create targeted, science-backed products addressing specific feline health concerns are well positioned to capture market share. The expansion of regulatory frameworks permitting the use of CBD in pet products across new geographies presents additional growth avenues through 2034, enabling brands to reach untapped consumer segments. Strategic partnerships with veterinarians, pet retailers, and e-commerce platforms can further enhance market penetration and brand visibility.

Another significant opportunity lies in the integration of advanced technologies and data analytics to personalize product offerings and improve customer engagement. The use of artificial intelligence and machine learning to analyze consumer preferences, purchase behaviors, and health outcomes can inform the development of customized CBD treat formulations and targeted marketing campaigns. Brands that leverage digital platforms to educate consumers about the benefits and safe use of CBD for cats can build trust and foster long-term loyalty. The rise of social media influencers and pet wellness communities offers additional avenues for organic growth and brand advocacy. Furthermore, the increasing demand for sustainable, ethically sourced, and organic ingredients presents an opportunity for differentiation and premiumization within the market.

Despite these opportunities, the market faces several restraining factors, chief among them being regulatory uncertainty and inconsistent product quality. The lack of harmonized global standards for CBD in pet products creates challenges for manufacturers seeking to expand internationally, as they must navigate a complex web of legal requirements and compliance obligations. Concerns about the safety, purity, and efficacy of CBD treats persist, particularly in markets where regulatory oversight is limited. The proliferation of unregulated or mislabeled products has the potential to erode consumer trust and hinder market growth. Addressing these challenges will require ongoing collaboration between industry stakeholders, regulators, and scientific institutions to establish clear guidelines, promote transparency, and ensure the highest standards of product safety and quality through the forecast period ending 2034.

CBD Calming Cat Treat Market Size by Region

The regional landscape of the CBD Calming Cat Treats market is marked by significant variation in market maturity, regulatory frameworks, and consumer preferences. North America leads the global market, generating approximately USD 179 million in revenue in 2025, driven by high pet ownership rates, a well-established CBD industry, and progressive regulatory policies. The United States accounts for the lion's share of regional sales, with Canada following closely behind. The region's robust e-commerce infrastructure and widespread acceptance of natural pet care products have further fueled growth. North America's market is projected to grow at a CAGR of 15.9% through 2034, supported by ongoing product innovation and expanding distribution networks.

Get Free Sample Report

Europe represents the second-largest regional market, with revenues of approximately USD 102 million in 2025. The region's growth is underpinned by increasing legalization of CBD products, rising consumer awareness, and a strong tradition of holistic pet care. Key markets such as the United Kingdom, Germany, and France are at the forefront of adoption, with regulatory clarity and consumer education initiatives driving uptake. European consumers tend to prioritize product safety, transparency, and sustainability, prompting manufacturers to invest in third-party certification and eco-friendly packaging. The region is expected to maintain a steady growth trajectory, with a projected CAGR of 16.6% through 2034 as more countries update their regulatory frameworks and embrace the benefits of CBD for pet wellness.

The Asia Pacific market, while currently smaller in scale at approximately USD 48 million in 2025, holds significant long-term growth potential. Rapid urbanization, rising disposable incomes, and changing attitudes toward pet ownership are driving increased demand for premium pet care products, including CBD-infused treats. Countries such as Japan, Australia, and South Korea are emerging as early adopters, with local manufacturers and international brands vying for market share. However, regulatory uncertainty and limited consumer awareness remain key challenges, necessitating ongoing education and advocacy efforts. Asia Pacific is projected to post the fastest regional CAGR of approximately 18.2% through 2034, making it a major future growth engine for the global market.

Latin America and the Middle East and Africa together account for approximately 11.5% of global market revenue in 2025, at around USD 24 million and USD 19 million respectively. Both regions are at earlier stages of market development, with consumer awareness and regulatory clarity still evolving. Brazil and Mexico are the primary growth markets in Latin America, while the UAE and South Africa lead adoption within the Middle East and Africa. As these regions progressively update their legal frameworks governing hemp-derived CBD and as premium pet care culture spreads, both are expected to deliver above-average growth rates through the 2026-2034 forecast period, contributing meaningfully to global market expansion.

CBD Calming Cat Treat Market Competitive Landscape

The competitive landscape of the CBD Calming Cat Treats market is characterized by a dynamic mix of established pet care brands, specialized CBD companies, and innovative startups. Intense competition has spurred a wave of product innovation, with companies racing to develop differentiated offerings that cater to specific feline health needs and consumer preferences. Key competitive factors include product quality, safety, palatability, and transparency, as well as the ability to secure distribution through trusted channels such as veterinary clinics and pet specialty stores. Companies are increasingly investing in research and development, third-party testing, and certifications to build consumer trust and comply with evolving regulatory standards through 2034.

Brand building and consumer education have emerged as critical success factors in the market, with leading companies leveraging digital marketing, influencer partnerships, and educational content to differentiate themselves and foster brand loyalty. The ability to communicate the benefits and safety of CBD in a clear, credible manner is essential for winning consumer trust, particularly in markets where skepticism or regulatory ambiguity persists. Strategic collaborations with veterinarians, animal health experts, and pet wellness organizations can further enhance brand credibility and drive adoption. As the market matures, consolidation is expected, with larger players acquiring innovative startups to expand their product portfolios and geographic reach.

Major companies operating in the CBD Calming Cat Treats market include HolistaPet, Pet Releaf, Charlotte's Web, Paw CBD (by cbdMD), Medterra, CBDfx, and Honest Paws. HolistaPet is renowned for its broad range of CBD-infused pet products, including cat-specific calming treats that leverage organic, non-GMO hemp. Pet Releaf differentiates itself through its commitment to full-spectrum formulations and sustainable sourcing, while Charlotte's Web is recognized for its vertically integrated supply chain and extensive research initiatives. Paw CBD, a subsidiary of cbdMD, has rapidly gained market share through its focus on veterinarian-formulated products and transparent labeling.

Medterra and CBDfx have leveraged their expertise in human CBD supplements to expand into the pet segment, offering a variety of treats and supplements tailored to feline wellness. Honest Paws is known for its third-party tested, all-natural treats that prioritize safety and efficacy. Green Roads, King Kanine, Austin and Kat, HempMy Pet, Anxious Pet, Canna-Pet, Joy Organics, and PureKana round out the competitive field, each carving distinct positions through unique formulation philosophies, distribution strategies, and brand storytelling. These companies are continuously innovating to stay ahead of regulatory changes and evolving consumer preferences, investing in new product development, clinical research, and global expansion as the market accelerates toward 2034.

Top Companies in the CBD Calming Cat Treat Market

• HolistaPet
• Honest Paws
• Paw CBD (by cbdMD)
• Charlotte's Web
• Pet Releaf
• Medterra
• Green Roads
• CBDfx
• King Kanine
• Austin and Kat
• HempMy Pet
• Anxious Pet
• Canna-Pet
• Joy Organics
• PureKana